Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Kodera R, Shikata K, Takatsuka T, Oda K, Miyamoto S, Kajitani N et al
We will send your medication to you so you can conveniently give yourself the injections at home rather than making weekly trips to one of our offices
Structure's GLP-1 Pill Could Be Big, But Trial Results Will Confirm Structure Therapeutics Today GPCR Structure Therapeutics $48.36 +0.32 (+0.67%) As of 04:00 PM Eastern 52-Week Range $15.80 $94.90 Price Target $110.55 Shares of Structure Therapeutics NASDAQ: GPCR have far outperformed both of the companies above in the last year, rising by over 150% during that time as investors have grown enthusiastic about aleniglipron, the firm's GLP-1 agonist candidate
US$ 27.28
US$ 25.18
US$ 26.69
US$ 29.56
US$ 27.64
US$ 23.11
US$ 26.80
US$ 25.69
US$ 25.49
US$ 26.48
US$ 25.36
US$ 25.41
